Adjustment of drug therapy and pharmaceutical care for a case of follicular non-Hodgkin lymphoma with persistent coronavirus positivity accompanied by Pneumocystis jirovecii pneumonia
A case of follicular non-Hodgkin lymphoma remained persistently positive for the coronavirus and developed acute respiratory distress syndrome(ARDS)after infection and his viral status did not revert to negative despite multiple courses of antiviral therapy,and meanwhile he experienced decrease in all three blood cell lines and developed secondary complications including Pneumocystis jirovecii pneumonia,bacterial infections and cytomegalovirus infection.Addressing the different stages of prolonged immunosuppression in the host,conflicting treatment strategies were identified.Considering the patient's evolving condition,medication characteristics,timely adjustments to drug therapy and pharmaceutical monitoring were implemented.The patient's overall condition was gradually improved.This case highlights the importance of capturing real-time primary contradictions in complex and evolving medical conditions,dynamically adjusting treatment plans.
follicular non-Hodgkin lymphomaCOVID-19Pneumocystis jirovecii pneumoniadrug therapy adjustmentpharmaceutical care
万方数据
维普
